CLAUDIA CANTU: Open Payments
NPI 1861986903 · KINGSVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$964 in 47 payments from 13 companies in 2025. Trend: 2023 $1,351 · 2024 $1,118 · 2025 $964
Food & beverage: $964
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $234 |
| Lilly USA, LLC | 15 | $219 |
| AstraZeneca Pharmaceuticals LP | 5 | $145 |
| Dexcom, Inc. | 1 | $122 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $85 |
| Exact Sciences Corporation | 2 | $42 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Amgen Inc. | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
Products named: MOUNJARO, Ozempic, FARXIGA, DEXCOM G7 GSS (161), JARDIANCE, Cologuard Collection Kit, Rybelsus, BREZTRI.
Industry payments across TX — which companies pay providers there.
